Uniwersytet Jagiellonski

Krzysztof Pyrc

Maria Nowakowska

Krzysztof Szczubialka

Kamil Kaminski

Justyna Ciejka

Magdalena Wytrwal

Aleksandra Synowiec

Aleksandra Milewska

Magdalena Pachota

Pawel Botwina

Magdalena Obloza

The present invention relates to a sulfonated polystyrene derivative of formula I for use in the treatment and/or prophylaxis of cat flu, especially infection caused by feline calicivirus or feline herpesvirus, alone or in combination therapy.

Sulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat flu

The subject of the invention is an N-sulfonic polyallylamine derivative (NSPAH) with Formula 1, wherein R is &#x2014;SOor &#x2014;H, and n is an integer from 150 to 15000; an application of the N-sulfonic polyallylamine derivative as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus; as well as a pharmaceutical composition comprising the N-sulfonic polyallylamine derivative and application thereof.

Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hMPV), human rhinoviruses (HRV), and infection by influenza virus type A (IAV) and pharmaceutical composition comprising the anionically modified polyallylamine derivative

Growing community of inventors

Cracow, Poland

Krzysztof Pyrc